SI-BONE, Inc. (SIBN)
NASDAQ: SIBN · IEX Real-Time Price · USD
14.57
+0.30 (2.10%)
At close: Apr 26, 2024, 4:00 PM
14.81
+0.24 (1.65%)
After-hours: Apr 26, 2024, 7:14 PM EDT
SI-BONE Revenue
In the year 2023, SI-BONE had annual revenue of $138.89M with 30.52% growth. Revenue in the quarter ending December 31, 2023 was $38.86M with 21.61% year-over-year growth.
Revenue (ttm)
$138.89M
Revenue Growth
+30.52%
P/S Ratio
4.31
Revenue / Employee
$403,738
Employees
344
Market Cap
598.31M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 138.89M | 32.48M | 30.52% |
| Dec 31, 2022 | 106.41M | 16.26M | 18.03% |
| Dec 31, 2021 | 90.15M | 16.77M | 22.84% |
| Dec 31, 2020 | 73.39M | 6.09M | 9.04% |
| Dec 31, 2019 | 67.30M | 11.92M | 21.53% |
| Dec 31, 2018 | 55.38M | 7.40M | 15.42% |
| Dec 31, 2017 | 47.98M | 5.88M | 13.97% |
| Dec 31, 2016 | 42.10M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cross Country Healthcare | 2.02B |
| Embecta | 1.12B |
| Accolade | 388.49M |
| Fulgent Genetics | 289.21M |
| Quanterix | 122.37M |
| Zymeworks | 76.01M |
SIBN News
- 11 days ago - SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024 - GlobeNewsWire
- 7 weeks ago - SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024 - GlobeNewsWire
- 2 months ago - SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance - GlobeNewsWire
- 2 months ago - SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024 - GlobeNewsWire
- 3 months ago - SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application - GlobeNewsWire
- 3 months ago - SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023 - GlobeNewsWire
- 5 months ago - SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023 - GlobeNewsWire
- 6 months ago - SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance - GlobeNewsWire